Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Gastric Cancer Market, by Route of Administration
1.4.2 Global Gastric Cancer Market, by Treatment Type
1.4.3 Global Gastric Cancer Market, by Disease Type
1.4.4 Global Gastric Cancer Market, by Distribution Channel
1.4.5 Global Gastric Cancer Market, by Drug Class
1.4.6 Global Gastric Cancer Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals & Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. Global Gastric Cancer Market by Route of Administration
4.1 Global Injectable Market by Region
4.2 Global Oral Market by Region
Chapter 5. Global Gastric Cancer Market by Treatment Type
5.1 Global Chemotherapy Market by Region
5.2 Global Targeted Therapy Market by Region
5.3 Global Immunotherapy Market by Region
5.4 Global Radiation Therapy & Surgery Market by Region
Chapter 6. Global Gastric Cancer Market by Disease Type
6.1 Global Adenocarcinoma Market by Region
6.2 Global Carcinoid Tumor Market by Region
6.3 Global Gastrointestinal Stromal Tumor Market by Region
6.4 Global Lymphoma Market by Region
6.5 Global Others Market by Region
Chapter 7. Global Gastric Cancer Market by Distribution Channel
7.1 Global Specialty & Retail Pharmacies Market by Region
7.2 Global Hospital Pharmacies Market by Region
7.3 Global Others Market by Region
Chapter 8. Global Gastric Cancer Market by Drug Class
8.1 Global PD-1/PD-L1 Inhibitors Market by Region
8.2 Global HER2 Antagonists Market by Region
8.3 Global VEGFR2 Antagonists Market by Region
8.4 Global Others Market by Region
Chapter 9. Global Gastric Cancer Market by Region
9.1 North America Gastric Cancer Market
9.1.1 North America Gastric Cancer Market by Route of Administration
9.1.1.1 North America Injectable Market by Country
9.1.1.2 North America Oral Market by Country
9.1.2 North America Gastric Cancer Market by Treatment Type
9.1.2.1 North America Chemotherapy Market by Country
9.1.2.2 North America Targeted Therapy Market by Country
9.1.2.3 North America Immunotherapy Market by Country
9.1.2.4 North America Radiation Therapy & Surgery Market by Country
9.1.3 North America Gastric Cancer Market by Disease Type
9.1.3.1 North America Adenocarcinoma Market by Country
9.1.3.2 North America Carcinoid Tumor Market by Country
9.1.3.3 North America Gastrointestinal Stromal Tumor Market by Country
9.1.3.4 North America Lymphoma Market by Country
9.1.3.5 North America Others Market by Country
9.1.4 North America Gastric Cancer Market by Distribution Channel
9.1.4.1 North America Specialty & Retail Pharmacies Market by Country
9.1.4.2 North America Hospital Pharmacies Market by Country
9.1.4.3 North America Others Market by Country
9.1.5 North America Gastric Cancer Market by Drug Class
9.1.5.1 North America PD-1/PD-L1 Inhibitors Market by Country
9.1.5.2 North America HER2 Antagonists Market by Country
9.1.5.3 North America VEGFR2 Antagonists Market by Country
9.1.5.4 North America Others Market by Country
9.1.6 North America Gastric Cancer Market by Country
9.1.6.1 US Gastric Cancer Market
9.1.6.1.1 US Gastric Cancer Market by Route of Administration
9.1.6.1.2 US Gastric Cancer Market by Treatment Type
9.1.6.1.3 US Gastric Cancer Market by Disease Type
9.1.6.1.4 US Gastric Cancer Market by Distribution Channel
9.1.6.1.5 US Gastric Cancer Market by Drug Class
9.1.6.2 Canada Gastric Cancer Market
9.1.6.2.1 Canada Gastric Cancer Market by Route of Administration
9.1.6.2.2 Canada Gastric Cancer Market by Treatment Type
9.1.6.2.3 Canada Gastric Cancer Market by Disease Type
9.1.6.2.4 Canada Gastric Cancer Market by Distribution Channel
9.1.6.2.5 Canada Gastric Cancer Market by Drug Class
9.1.6.3 Mexico Gastric Cancer Market
9.1.6.3.1 Mexico Gastric Cancer Market by Route of Administration
9.1.6.3.2 Mexico Gastric Cancer Market by Treatment Type
9.1.6.3.3 Mexico Gastric Cancer Market by Disease Type
9.1.6.3.4 Mexico Gastric Cancer Market by Distribution Channel
9.1.6.3.5 Mexico Gastric Cancer Market by Drug Class
9.1.6.4 Rest of North America Gastric Cancer Market
9.1.6.4.1 Rest of North America Gastric Cancer Market by Route of Administration
9.1.6.4.2 Rest of North America Gastric Cancer Market by Treatment Type
9.1.6.4.3 Rest of North America Gastric Cancer Market by Disease Type
9.1.6.4.4 Rest of North America Gastric Cancer Market by Distribution Channel
9.1.6.4.5 Rest of North America Gastric Cancer Market by Drug Class
9.2 Europe Gastric Cancer Market
9.2.1 Europe Gastric Cancer Market by Route of Administration
9.2.1.1 Europe Injectable Market by Country
9.2.1.2 Europe Oral Market by Country
9.2.2 Europe Gastric Cancer Market by Treatment Type
9.2.2.1 Europe Chemotherapy Market by Country
9.2.2.2 Europe Targeted Therapy Market by Country
9.2.2.3 Europe Immunotherapy Market by Country
9.2.2.4 Europe Radiation Therapy & Surgery Market by Country
9.2.3 Europe Gastric Cancer Market by Disease Type
9.2.3.1 Europe Adenocarcinoma Market by Country
9.2.3.2 Europe Carcinoid Tumor Market by Country
9.2.3.3 Europe Gastrointestinal Stromal Tumor Market by Country
9.2.3.4 Europe Lymphoma Market by Country
9.2.3.5 Europe Others Market by Country
9.2.4 Europe Gastric Cancer Market by Distribution Channel
9.2.4.1 Europe Specialty & Retail Pharmacies Market by Country
9.2.4.2 Europe Hospital Pharmacies Market by Country
9.2.4.3 Europe Others Market by Country
9.2.5 Europe Gastric Cancer Market by Drug Class
9.2.5.1 Europe PD-1/PD-L1 Inhibitors Market by Country
9.2.5.2 Europe HER2 Antagonists Market by Country
9.2.5.3 Europe VEGFR2 Antagonists Market by Country
9.2.5.4 Europe Others Market by Country
9.2.6 Europe Gastric Cancer Market by Country
9.2.6.1 Germany Gastric Cancer Market
9.2.6.1.1 Germany Gastric Cancer Market by Route of Administration
9.2.6.1.2 Germany Gastric Cancer Market by Treatment Type
9.2.6.1.3 Germany Gastric Cancer Market by Disease Type
9.2.6.1.4 Germany Gastric Cancer Market by Distribution Channel
9.2.6.1.5 Germany Gastric Cancer Market by Drug Class
9.2.6.2 UK Gastric Cancer Market
9.2.6.2.1 UK Gastric Cancer Market by Route of Administration
9.2.6.2.2 UK Gastric Cancer Market by Treatment Type
9.2.6.2.3 UK Gastric Cancer Market by Disease Type
9.2.6.2.4 UK Gastric Cancer Market by Distribution Channel
9.2.6.2.5 UK Gastric Cancer Market by Drug Class
9.2.6.3 France Gastric Cancer Market
9.2.6.3.1 France Gastric Cancer Market by Route of Administration
9.2.6.3.2 France Gastric Cancer Market by Treatment Type
9.2.6.3.3 France Gastric Cancer Market by Disease Type
9.2.6.3.4 France Gastric Cancer Market by Distribution Channel
9.2.6.3.5 France Gastric Cancer Market by Drug Class
9.2.6.4 Russia Gastric Cancer Market
9.2.6.4.1 Russia Gastric Cancer Market by Route of Administration
9.2.6.4.2 Russia Gastric Cancer Market by Treatment Type
9.2.6.4.3 Russia Gastric Cancer Market by Disease Type
9.2.6.4.4 Russia Gastric Cancer Market by Distribution Channel
9.2.6.4.5 Russia Gastric Cancer Market by Drug Class
9.2.6.5 Spain Gastric Cancer Market
9.2.6.5.1 Spain Gastric Cancer Market by Route of Administration
9.2.6.5.2 Spain Gastric Cancer Market by Treatment Type
9.2.6.5.3 Spain Gastric Cancer Market by Disease Type
9.2.6.5.4 Spain Gastric Cancer Market by Distribution Channel
9.2.6.5.5 Spain Gastric Cancer Market by Drug Class
9.2.6.6 Italy Gastric Cancer Market
9.2.6.6.1 Italy Gastric Cancer Market by Route of Administration
9.2.6.6.2 Italy Gastric Cancer Market by Treatment Type
9.2.6.6.3 Italy Gastric Cancer Market by Disease Type
9.2.6.6.4 Italy Gastric Cancer Market by Distribution Channel
9.2.6.6.5 Italy Gastric Cancer Market by Drug Class
9.2.6.7 Rest of Europe Gastric Cancer Market
9.2.6.7.1 Rest of Europe Gastric Cancer Market by Route of Administration
9.2.6.7.2 Rest of Europe Gastric Cancer Market by Treatment Type
9.2.6.7.3 Rest of Europe Gastric Cancer Market by Disease Type
9.2.6.7.4 Rest of Europe Gastric Cancer Market by Distribution Channel
9.2.6.7.5 Rest of Europe Gastric Cancer Market by Drug Class
9.3 Asia Pacific Gastric Cancer Market
9.3.1 Asia Pacific Gastric Cancer Market by Route of Administration
9.3.1.1 Asia Pacific Injectable Market by Country
9.3.1.2 Asia Pacific Oral Market by Country
9.3.2 Asia Pacific Gastric Cancer Market by Treatment Type
9.3.2.1 Asia Pacific Chemotherapy Market by Country
9.3.2.2 Asia Pacific Targeted Therapy Market by Country
9.3.2.3 Asia Pacific Immunotherapy Market by Country
9.3.2.4 Asia Pacific Radiation Therapy & Surgery Market by Country
9.3.3 Asia Pacific Gastric Cancer Market by Disease Type
9.3.3.1 Asia Pacific Adenocarcinoma Market by Country
9.3.3.2 Asia Pacific Carcinoid Tumor Market by Country
9.3.3.3 Asia Pacific Gastrointestinal Stromal Tumor Market by Country
9.3.3.4 Asia Pacific Lymphoma Market by Country
9.3.3.5 Asia Pacific Others Market by Country
9.3.4 Asia Pacific Gastric Cancer Market by Distribution Channel
9.3.4.1 Asia Pacific Specialty & Retail Pharmacies Market by Country
9.3.4.2 Asia Pacific Hospital Pharmacies Market by Country
9.3.4.3 Asia Pacific Others Market by Country
9.3.5 Asia Pacific Gastric Cancer Market by Drug Class
9.3.5.1 Asia Pacific PD-1/PD-L1 Inhibitors Market by Country
9.3.5.2 Asia Pacific HER2 Antagonists Market by Country
9.3.5.3 Asia Pacific VEGFR2 Antagonists Market by Country
9.3.5.4 Asia Pacific Others Market by Country
9.3.6 Asia Pacific Gastric Cancer Market by Country
9.3.6.1 China Gastric Cancer Market
9.3.6.1.1 China Gastric Cancer Market by Route of Administration
9.3.6.1.2 China Gastric Cancer Market by Treatment Type
9.3.6.1.3 China Gastric Cancer Market by Disease Type
9.3.6.1.4 China Gastric Cancer Market by Distribution Channel
9.3.6.1.5 China Gastric Cancer Market by Drug Class
9.3.6.2 Japan Gastric Cancer Market
9.3.6.2.1 Japan Gastric Cancer Market by Route of Administration
9.3.6.2.2 Japan Gastric Cancer Market by Treatment Type
9.3.6.2.3 Japan Gastric Cancer Market by Disease Type
9.3.6.2.4 Japan Gastric Cancer Market by Distribution Channel
9.3.6.2.5 Japan Gastric Cancer Market by Drug Class
9.3.6.3 India Gastric Cancer Market
9.3.6.3.1 India Gastric Cancer Market by Route of Administration
9.3.6.3.2 India Gastric Cancer Market by Treatment Type
9.3.6.3.3 India Gastric Cancer Market by Disease Type
9.3.6.3.4 India Gastric Cancer Market by Distribution Channel
9.3.6.3.5 India Gastric Cancer Market by Drug Class
9.3.6.4 South Korea Gastric Cancer Market
9.3.6.4.1 South Korea Gastric Cancer Market by Route of Administration
9.3.6.4.2 South Korea Gastric Cancer Market by Treatment Type
9.3.6.4.3 South Korea Gastric Cancer Market by Disease Type
9.3.6.4.4 South Korea Gastric Cancer Market by Distribution Channel
9.3.6.4.5 South Korea Gastric Cancer Market by Drug Class
9.3.6.5 Singapore Gastric Cancer Market
9.3.6.5.1 Singapore Gastric Cancer Market by Route of Administration
9.3.6.5.2 Singapore Gastric Cancer Market by Treatment Type
9.3.6.5.3 Singapore Gastric Cancer Market by Disease Type
9.3.6.5.4 Singapore Gastric Cancer Market by Distribution Channel
9.3.6.5.5 Singapore Gastric Cancer Market by Drug Class
9.3.6.6 Malaysia Gastric Cancer Market
9.3.6.6.1 Malaysia Gastric Cancer Market by Route of Administration
9.3.6.6.2 Malaysia Gastric Cancer Market by Treatment Type
9.3.6.6.3 Malaysia Gastric Cancer Market by Disease Type
9.3.6.6.4 Malaysia Gastric Cancer Market by Distribution Channel
9.3.6.6.5 Malaysia Gastric Cancer Market by Drug Class
9.3.6.7 Rest of Asia Pacific Gastric Cancer Market
9.3.6.7.1 Rest of Asia Pacific Gastric Cancer Market by Route of Administration
9.3.6.7.2 Rest of Asia Pacific Gastric Cancer Market by Treatment Type
9.3.6.7.3 Rest of Asia Pacific Gastric Cancer Market by Disease Type
9.3.6.7.4 Rest of Asia Pacific Gastric Cancer Market by Distribution Channel
9.3.6.7.5 Rest of Asia Pacific Gastric Cancer Market by Drug Class
9.4 LAMEA Gastric Cancer Market
9.4.1 LAMEA Gastric Cancer Market by Route of Administration
9.4.1.1 LAMEA Injectable Market by Country
9.4.1.2 LAMEA Oral Market by Country
9.4.2 LAMEA Gastric Cancer Market by Treatment Type
9.4.2.1 LAMEA Chemotherapy Market by Country
9.4.2.2 LAMEA Targeted Therapy Market by Country
9.4.2.3 LAMEA Immunotherapy Market by Country
9.4.2.4 LAMEA Radiation Therapy & Surgery Market by Country
9.4.3 LAMEA Gastric Cancer Market by Disease Type
9.4.3.1 LAMEA Adenocarcinoma Market by Country
9.4.3.2 LAMEA Carcinoid Tumor Market by Country
9.4.3.3 LAMEA Gastrointestinal Stromal Tumor Market by Country
9.4.3.4 LAMEA Lymphoma Market by Country
9.4.3.5 LAMEA Others Market by Country
9.4.4 LAMEA Gastric Cancer Market by Distribution Channel
9.4.4.1 LAMEA Specialty & Retail Pharmacies Market by Country
9.4.4.2 LAMEA Hospital Pharmacies Market by Country
9.4.4.3 LAMEA Others Market by Country
9.4.5 LAMEA Gastric Cancer Market by Drug Class
9.4.5.1 LAMEA PD-1/PD-L1 Inhibitors Market by Country
9.4.5.2 LAMEA HER2 Antagonists Market by Country
9.4.5.3 LAMEA VEGFR2 Antagonists Market by Country
9.4.5.4 LAMEA Others Market by Country
9.4.6 LAMEA Gastric Cancer Market by Country
9.4.6.1 Brazil Gastric Cancer Market
9.4.6.1.1 Brazil Gastric Cancer Market by Route of Administration
9.4.6.1.2 Brazil Gastric Cancer Market by Treatment Type
9.4.6.1.3 Brazil Gastric Cancer Market by Disease Type
9.4.6.1.4 Brazil Gastric Cancer Market by Distribution Channel
9.4.6.1.5 Brazil Gastric Cancer Market by Drug Class
9.4.6.2 Argentina Gastric Cancer Market
9.4.6.2.1 Argentina Gastric Cancer Market by Route of Administration
9.4.6.2.2 Argentina Gastric Cancer Market by Treatment Type
9.4.6.2.3 Argentina Gastric Cancer Market by Disease Type
9.4.6.2.4 Argentina Gastric Cancer Market by Distribution Channel
9.4.6.2.5 Argentina Gastric Cancer Market by Drug Class
9.4.6.3 UAE Gastric Cancer Market
9.4.6.3.1 UAE Gastric Cancer Market by Route of Administration
9.4.6.3.2 UAE Gastric Cancer Market by Treatment Type
9.4.6.3.3 UAE Gastric Cancer Market by Disease Type
9.4.6.3.4 UAE Gastric Cancer Market by Distribution Channel
9.4.6.3.5 UAE Gastric Cancer Market by Drug Class
9.4.6.4 Saudi Arabia Gastric Cancer Market
9.4.6.4.1 Saudi Arabia Gastric Cancer Market by Route of Administration
9.4.6.4.2 Saudi Arabia Gastric Cancer Market by Treatment Type
9.4.6.4.3 Saudi Arabia Gastric Cancer Market by Disease Type
9.4.6.4.4 Saudi Arabia Gastric Cancer Market by Distribution Channel
9.4.6.4.5 Saudi Arabia Gastric Cancer Market by Drug Class
9.4.6.5 South Africa Gastric Cancer Market
9.4.6.5.1 South Africa Gastric Cancer Market by Route of Administration
9.4.6.5.2 South Africa Gastric Cancer Market by Treatment Type
9.4.6.5.3 South Africa Gastric Cancer Market by Disease Type
9.4.6.5.4 South Africa Gastric Cancer Market by Distribution Channel
9.4.6.5.5 South Africa Gastric Cancer Market by Drug Class
9.4.6.6 Nigeria Gastric Cancer Market
9.4.6.6.1 Nigeria Gastric Cancer Market by Route of Administration
9.4.6.6.2 Nigeria Gastric Cancer Market by Treatment Type
9.4.6.6.3 Nigeria Gastric Cancer Market by Disease Type
9.4.6.6.4 Nigeria Gastric Cancer Market by Distribution Channel
9.4.6.6.5 Nigeria Gastric Cancer Market by Drug Class
9.4.6.7 Rest of LAMEA Gastric Cancer Market
9.4.6.7.1 Rest of LAMEA Gastric Cancer Market by Route of Administration
9.4.6.7.2 Rest of LAMEA Gastric Cancer Market by Treatment Type
9.4.6.7.3 Rest of LAMEA Gastric Cancer Market by Disease Type
9.4.6.7.4 Rest of LAMEA Gastric Cancer Market by Distribution Channel
9.4.6.7.5 Rest of LAMEA Gastric Cancer Market by Drug Class
Chapter 10. Company Profiles
10.1 Novartis AG
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.2 Pfizer, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional & Segmental Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.3 Viatris, Inc. (Mylan N.V.)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.5.2 Approvals & Trials:
10.4 F. Hoffmann-La Roche Ltd.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Product Launches and Product Expansions:
10.5 Eli Lilly And Company
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Approvals & Trials:
10.5.5.2 Partnerships, Collaborations, and Agreements:
10.6 Merck & Co., Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 Recent strategies and developments:
10.7.5.1 Product Launches and Product Expansions:
10.7.5.2 Approvals & Trials:
10.7.5.3 Partnerships, Collaborations, and Agreements:
10.8 Bristol Myers Squibb Company
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Approvals & Trials:
10.9 Celltrion Healthcare Co., Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Recent strategies and developments:
10.9.3.1 Partnerships, Collaborations, and Agreements:
10.10. Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.)
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expenses
10.10.5 Recent strategies and developments:
10.10.5.1 Approvals & Trials:
10.10.5.2 Product Launches and Product Expansions:



List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Global Gastric Cancer Market share by Route of Administration, 2022
FIG 5 Global Gastric Cancer Market share by Route of Administration, 2029
FIG 6 Global Gastric Cancer Market by Route of Administration, 2019 - 2029, USD Million
FIG 7 Global Gastric Cancer Market share by Treatment Type, 2022
FIG 8 Global Gastric Cancer Market share by Treatment Type, 2029
FIG 9 Global Gastric Cancer Market by Treatment Type, 2019 - 2029, USD Million
FIG 10 Global Gastric Cancer Market share by Disease Type, 2022
FIG 11 Global Gastric Cancer Market share by Disease Type, 2029
FIG 12 Global Gastric Cancer Market by Disease Type, 2019 - 2029, USD Million
FIG 13 Global Gastric Cancer Market share by Distribution Channel, 2022
FIG 14 Global Gastric Cancer Market share by Distribution Channel, 2029
FIG 15 Global Gastric Cancer Market by Distribution Channel, 2019 - 2029, USD Million
FIG 16 Global Gastric Cancer Market share by Drug Class, 2022
FIG 17 Global Gastric Cancer Market share by Drug Class, 2029
FIG 18 Global Gastric Cancer Market by Drug Class, 2019 - 2029, USD Million
FIG 19 Global Gastric Cancer Market share by Region, 2022
FIG 20 Global Gastric Cancer Market share by Region, 2029
FIG 21 Global Gastric Cancer Market by Region, 2019 - 2029, USD Million
FIG 22 Recent strategies and developments: Viatris, Inc.
FIG 23 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 24 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 25 Recent strategies and developments: Samsung Biologics Co., Ltd.

List of Tables

TABLE 1 Global Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 2 Global Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Gastric Cancer Market
TABLE 4 Product Launches And Product Expansions– Gastric Cancer Market
TABLE 5 Approvals & Trials – Gastric Cancer Market
TABLE 6 Global Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 7 Global Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 8 Global Injectable Market by Region, 2019 - 2022, USD Million
TABLE 9 Global Injectable Market by Region, 2023 - 2029, USD Million
TABLE 10 Global Oral Market by Region, 2019 - 2022, USD Million
TABLE 11 Global Oral Market by Region, 2023 - 2029, USD Million
TABLE 12 Global Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 13 Global Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 14 Global Chemotherapy Market by Region, 2019 - 2022, USD Million
TABLE 15 Global Chemotherapy Market by Region, 2023 - 2029, USD Million
TABLE 16 Global Targeted Therapy Market by Region, 2019 - 2022, USD Million
TABLE 17 Global Targeted Therapy Market by Region, 2023 - 2029, USD Million
TABLE 18 Global Immunotherapy?Market by Region, 2019 - 2022, USD Million
TABLE 19 Global Immunotherapy?Market by Region, 2023 - 2029, USD Million
TABLE 20 Global Radiation Therapy & Surgery Market by Region, 2019 - 2022, USD Million
TABLE 21 Global Radiation Therapy & Surgery Market by Region, 2023 - 2029, USD Million
TABLE 22 Global Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 23 Global Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 24 Global Adenocarcinoma Market by Region, 2019 - 2022, USD Million
TABLE 25 Global Adenocarcinoma Market by Region, 2023 - 2029, USD Million
TABLE 26 Global Carcinoid Tumor Market by Region, 2019 - 2022, USD Million
TABLE 27 Global Carcinoid Tumor Market by Region, 2023 - 2029, USD Million
TABLE 28 Global Gastrointestinal Stromal Tumor Market by Region, 2019 - 2022, USD Million
TABLE 29 Global Gastrointestinal Stromal Tumor Market by Region, 2023 - 2029, USD Million
TABLE 30 Global Lymphoma Market by Region, 2019 - 2022, USD Million
TABLE 31 Global Lymphoma Market by Region, 2023 - 2029, USD Million
TABLE 32 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 33 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 34 Global Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 35 Global Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 36 Global Specialty & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 37 Global Specialty & Retail Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 38 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 39 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 40 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 41 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 42 Global Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 43 Global Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 44 Global PD-1/PD-L1 Inhibitors Market by Region, 2019 - 2022, USD Million
TABLE 45 Global PD-1/PD-L1 Inhibitors Market by Region, 2023 - 2029, USD Million
TABLE 46 Global HER2 Antagonists Market by Region, 2019 - 2022, USD Million
TABLE 47 Global HER2 Antagonists Market by Region, 2023 - 2029, USD Million
TABLE 48 Global VEGFR2 Antagonists Market by Region, 2019 - 2022, USD Million
TABLE 49 Global VEGFR2 Antagonists Market by Region, 2023 - 2029, USD Million
TABLE 50 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 51 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 52 Global Gastric Cancer Market by Region, 2019 - 2022, USD Million
TABLE 53 Global Gastric Cancer Market by Region, 2023 - 2029, USD Million
TABLE 54 North America Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 55 North America Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 56 North America Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 57 North America Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 58 North America Injectable Market by Country, 2019 - 2022, USD Million
TABLE 59 North America Injectable Market by Country, 2023 - 2029, USD Million
TABLE 60 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 61 North America Oral Market by Country, 2023 - 2029, USD Million
TABLE 62 North America Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 63 North America Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 64 North America Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 65 North America Chemotherapy Market by Country, 2023 - 2029, USD Million
TABLE 66 North America Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 67 North America Targeted Therapy Market by Country, 2023 - 2029, USD Million
TABLE 68 North America Immunotherapy?Market by Country, 2019 - 2022, USD Million
TABLE 69 North America Immunotherapy?Market by Country, 2023 - 2029, USD Million
TABLE 70 North America Radiation Therapy & Surgery Market by Country, 2019 - 2022, USD Million
TABLE 71 North America Radiation Therapy & Surgery Market by Country, 2023 - 2029, USD Million
TABLE 72 North America Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 73 North America Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 74 North America Adenocarcinoma Market by Country, 2019 - 2022, USD Million
TABLE 75 North America Adenocarcinoma Market by Country, 2023 - 2029, USD Million
TABLE 76 North America Carcinoid Tumor Market by Country, 2019 - 2022, USD Million
TABLE 77 North America Carcinoid Tumor Market by Country, 2023 - 2029, USD Million
TABLE 78 North America Gastrointestinal Stromal Tumor Market by Country, 2019 - 2022, USD Million
TABLE 79 North America Gastrointestinal Stromal Tumor Market by Country, 2023 - 2029, USD Million
TABLE 80 North America Lymphoma Market by Country, 2019 - 2022, USD Million
TABLE 81 North America Lymphoma Market by Country, 2023 - 2029, USD Million
TABLE 82 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 83 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 84 North America Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 85 North America Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 86 North America Specialty & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 87 North America Specialty & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 88 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 89 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 90 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 91 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 92 North America Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 93 North America Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 94 North America PD-1/PD-L1 Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 95 North America PD-1/PD-L1 Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 96 North America HER2 Antagonists Market by Country, 2019 - 2022, USD Million
TABLE 97 North America HER2 Antagonists Market by Country, 2023 - 2029, USD Million
TABLE 98 North America VEGFR2 Antagonists Market by Country, 2019 - 2022, USD Million
TABLE 99 North America VEGFR2 Antagonists Market by Country, 2023 - 2029, USD Million
TABLE 100 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 101 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 102 North America Gastric Cancer Market by Country, 2019 - 2022, USD Million
TABLE 103 North America Gastric Cancer Market by Country, 2023 - 2029, USD Million
TABLE 104 US Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 105 US Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 106 US Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 107 US Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 108 US Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 109 US Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 110 US Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 111 US Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 112 US Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 113 US Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 114 US Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 115 US Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 116 Canada Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 117 Canada Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 118 Canada Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 119 Canada Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 120 Canada Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 121 Canada Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 122 Canada Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 123 Canada Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 124 Canada Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 125 Canada Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 126 Canada Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 127 Canada Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 128 Mexico Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 129 Mexico Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 130 Mexico Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 131 Mexico Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 132 Mexico Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 133 Mexico Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 134 Mexico Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 135 Mexico Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 136 Mexico Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 137 Mexico Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 138 Mexico Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 139 Mexico Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 140 Rest of North America Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 141 Rest of North America Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 142 Rest of North America Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 143 Rest of North America Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 144 Rest of North America Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 145 Rest of North America Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 146 Rest of North America Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 147 Rest of North America Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 148 Rest of North America Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 149 Rest of North America Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 150 Rest of North America Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 151 Rest of North America Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 152 Europe Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 153 Europe Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 154 Europe Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 155 Europe Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 156 Europe Injectable Market by Country, 2019 - 2022, USD Million
TABLE 157 Europe Injectable Market by Country, 2023 - 2029, USD Million
TABLE 158 Europe Oral Market by Country, 2019 - 2022, USD Million
TABLE 159 Europe Oral Market by Country, 2023 - 2029, USD Million
TABLE 160 Europe Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 161 Europe Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 162 Europe Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 163 Europe Chemotherapy Market by Country, 2023 - 2029, USD Million
TABLE 164 Europe Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 165 Europe Targeted Therapy Market by Country, 2023 - 2029, USD Million
TABLE 166 Europe Immunotherapy?Market by Country, 2019 - 2022, USD Million
TABLE 167 Europe Immunotherapy?Market by Country, 2023 - 2029, USD Million
TABLE 168 Europe Radiation Therapy & Surgery Market by Country, 2019 - 2022, USD Million
TABLE 169 Europe Radiation Therapy & Surgery Market by Country, 2023 - 2029, USD Million
TABLE 170 Europe Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 171 Europe Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 172 Europe Adenocarcinoma Market by Country, 2019 - 2022, USD Million
TABLE 173 Europe Adenocarcinoma Market by Country, 2023 - 2029, USD Million
TABLE 174 Europe Carcinoid Tumor Market by Country, 2019 - 2022, USD Million
TABLE 175 Europe Carcinoid Tumor Market by Country, 2023 - 2029, USD Million
TABLE 176 Europe Gastrointestinal Stromal Tumor Market by Country, 2019 - 2022, USD Million
TABLE 177 Europe Gastrointestinal Stromal Tumor Market by Country, 2023 - 2029, USD Million
TABLE 178 Europe Lymphoma Market by Country, 2019 - 2022, USD Million
TABLE 179 Europe Lymphoma Market by Country, 2023 - 2029, USD Million
TABLE 180 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 181 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 182 Europe Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 183 Europe Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 184 Europe Specialty & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 185 Europe Specialty & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 186 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 187 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 188 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 189 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 190 Europe Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 191 Europe Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 192 Europe PD-1/PD-L1 Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 193 Europe PD-1/PD-L1 Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 194 Europe HER2 Antagonists Market by Country, 2019 - 2022, USD Million
TABLE 195 Europe HER2 Antagonists Market by Country, 2023 - 2029, USD Million
TABLE 196 Europe VEGFR2 Antagonists Market by Country, 2019 - 2022, USD Million
TABLE 197 Europe VEGFR2 Antagonists Market by Country, 2023 - 2029, USD Million
TABLE 198 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 199 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 200 Europe Gastric Cancer Market by Country, 2019 - 2022, USD Million
TABLE 201 Europe Gastric Cancer Market by Country, 2023 - 2029, USD Million
TABLE 202 Germany Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 203 Germany Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 204 Germany Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 205 Germany Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 206 Germany Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 207 Germany Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 208 Germany Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 209 Germany Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 210 Germany Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 211 Germany Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 212 Germany Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 213 Germany Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 214 UK Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 215 UK Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 216 UK Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 217 UK Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 218 UK Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 219 UK Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 220 UK Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 221 UK Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 222 UK Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 223 UK Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 224 UK Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 225 UK Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 226 France Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 227 France Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 228 France Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 229 France Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 230 France Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 231 France Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 232 France Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 233 France Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 234 France Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 235 France Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 236 France Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 237 France Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 238 Russia Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 239 Russia Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 240 Russia Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 241 Russia Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 242 Russia Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 243 Russia Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 244 Russia Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 245 Russia Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 246 Russia Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 247 Russia Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 248 Russia Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 249 Russia Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 250 Spain Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 251 Spain Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 252 Spain Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 253 Spain Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 254 Spain Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 255 Spain Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 256 Spain Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 257 Spain Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 258 Spain Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 259 Spain Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 260 Spain Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 261 Spain Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 262 Italy Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 263 Italy Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 264 Italy Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 265 Italy Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 266 Italy Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 267 Italy Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 268 Italy Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 269 Italy Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 270 Italy Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 271 Italy Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 272 Italy Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 273 Italy Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 274 Rest of Europe Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 275 Rest of Europe Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 276 Rest of Europe Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 277 Rest of Europe Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 278 Rest of Europe Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 279 Rest of Europe Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 280 Rest of Europe Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 281 Rest of Europe Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 282 Rest of Europe Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 283 Rest of Europe Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 284 Rest of Europe Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 285 Rest of Europe Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million